NUVAIRA, INC.
Profile
Company Names
NUVAIRA, INC.
HOLAIRA, INC.
INNOVATIVE PULMONARY SOLUTIONS, INC.
Addresses
6500 WEDGWOOD ROAD NORTH, SUITE 100, MAPLE GROVE, MN 55311
6500 WEDGWOOD ROAD NORTH, SUITE 100, MINNEAPOLIS, MN 55311
3750 ANNAPOLIS LANE NORTH, SUITE 105, PLYMOUTH, MN 55447
3750 ANNAPOLIS LANE NORTH, SUITE 105, PLYMOUTH, MN 55447
1750 112TH AVENUE NE, SUITE D-255, BELLEVUE, WA 98004
12810 NE 32ND PLACE, BELLEVUE, WA 98005
Phone Numbers
763-450-2800
(763) 450-2800
(206) 327-4284
Entity Type:
CORPORATION
Industry:
OTHER HEALTH CARE, OTHER
Year Incorporated:
2008
State Incorporated:
DE
Total Amount Raised:
$177,942,639.00
Number of Funding Rounds:
12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2026-02-20
$35,764,878.00
$63,576,279.00
$27,811,401.00
Equity
11
2025-08-11
$979,184.00
$2,500,000.00
$1,520,816.00
10
2024-04-24
$52,875.00
$56,382.00
$3,507.00
Equity
9
2023-11-28
$15,124,893.00
$17,251,125.00
$2,126,232.00
Equity
8
2020-07-13
$31,337,640.00
$68,228,304.00
$36,890,664.00
Equity
7
2019-02-07
$25,000,004.00
$75,000,000.00
$49,999,996.00
Equity
6
2018-04-06
$4,000,011.00
$8,000,023.00
$4,000,012.00
Debt
5
2014-04-02
$42,000,011.00
$42,000,011.00
$0.00
Equity
4
2013-02-08
$10,000,000.00
$10,000,000.00
$0.00
Equity
3
2012-03-23
$10,600,007.00
$10,600,007.00
$0.00
Equity
2
2010-09-15
$3,000,000.00
$8,000,000.00
$5,000,000.00
Equity
1
2009-03-31
$83,136.00
$500,000.00
$416,864.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
A.
CARUSI
DIRECTOR
HOLAIRA, INC.
| LIGHTSTONE VENTURES, L.P.
| LIGHTSTONE VENTURES (A), L.P.
| LIGHTSTONE VENTURES (AIV), L.P.
| LIGHTSTONE VENTURES (A) (AIV), L.P.
| LIGHTSTONE SINGAPORE, L.P.
| CALA HEALTH, INC.
| NUVAIRA, INC.
| FOUNDRY THERAPEUTICS 1, INC.
| MEDISIX THERAPEUTICS, INC.
| ALLAY THERAPEUTICS, INC.
| LIGHTSTONE VENTURES III, L.P.
| APREO HEALTH, INC.
MIKE
CARUSI
DIRECTOR
MARK
DEEM
DIRECTOR
FOUNDRY NEWCO XII, INC.
| CABOCHON AESTHETICS INC
| MIRAMAR LABS INC
| INNOVATIVE PULMONARY SOLUTIONS, INC.
| COTERA, INC.
| HOLAIRA, INC.
| TWELVE, INC.
| MIRAMAR LABS, INC.
| CALA HEALTH, INC.
| MIRAMAR LABS, INC.
| HAT TRICK MEDICAL, INC.
| NUVAIRA, INC.
| HALF MOON MEDICAL, INC.
| FOUNDRY THERAPEUTICS 1, INC.
| ALLAY THERAPEUTICS, INC.
| PLEURAL DYNAMICS, INC.
MARTIN
L.
MAYSE
EXECUTIVE OFFICER, DIRECTOR
CAROLYN
NG
DIRECTOR
KIRK
NIELSEN
DIRECTOR
INCEPTUS NEWCO1 INC.
| ZYGA TECHNOLOGY, INC.
| INNOVATIVE PULMONARY SOLUTIONS, INC.
| MEDICAL DEVICE INNOVATIONS, INC.
| HOLAIRA, INC.
| RESPICARDIA, INC.
| INARI MEDICAL, INC.
| VERSANT VENTURE CAPITAL V, L.P.
| VERSANT AFFILIATES FUND V, L.P.
| VERSANT OPHTHALMIC AFFILIATES I, L.P.
| VERSANT VENTURE CAPITAL V (CANADA), LP
| NEUWAVE MEDICAL, INC.
| CETERIX ORTHOPAEDICS, INC.
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| VERSANT VENTURE CAPITAL VI, L.P.
| METAVENTION, INC.
| NUVAIRA, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| MONTERIS MEDICAL US, INC.
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| ALLEVIANT MEDICAL, INC.
| CVRX, INC.
| SPYGLASS OPHTHALMICS, INC.
| MOXE HEALTH CORP
| ARTELON, INC.
| IVEACARE, INC.
| RAMPART IC, INC.
| VI1, INC.
| OKAMI MEDICAL, INC.
HANK
PLAIN
DIRECTOR
HENRY
A.
PLAIN
DIRECTOR
GARY
RIESCHEL
DIRECTOR
JONATHAN
ROOT
DIRECTOR
SEQUENT MEDICAL, INC.
| LUTONIX INC
| INCEPTUS NEWCO1 INC.
| ONCOMED PHARMACEUTICALS INC
| INARI MEDICAL, INC.
| OMADA HEALTH, INC.
| EFFECTOR THERAPEUTICS, INC.
| RIBON THERAPEUTICS, INC.
| ROUTE 92 MEDICAL, INC.
| AIS VGP-6, LLC
| CLEAVE BIOSCIENCES, INC.
| NUVAIRA, INC.
| HEALTHJOY, INC.
| OKAMI MEDICAL, INC.
| EDGEWISE THERAPEUTICS, INC.
| SWOOP.COM, INC
| SILVERBACK THERAPEUTICS, INC.
| EL CAMINO REAL MEDICAL, INC.
| HIGHWAY 1 MEDICAL, INC.
| CARLSMED, INC.
| SURGICAL SAFETY TECHNOLOGIES INC.
| SPARROW PHARMACEUTICALS, INC.
ALEXANDER
SCHMITZ
DIRECTOR
CHRISTOPHER
SHEN
DIRECTOR
DAVE
STASSEN
DIRECTOR
DAVID
STASSEN
DIRECTOR
DENNIS
W.
WAHR
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

